Navigation Links
Breaking news: Study revives Olympic prospects for amputee sprinter

A world-renowned team of experts in biomechanics and physiology from six universities, led by Professor Hugh Herr of the Massachusetts Institute of Technologys Media Lab, refute scientific claims that the prostheses worn by Oscar Pistorius, a 21-year-old South African bilateral amputee track athlete, provide him with an unfair advantage in the 400-meter race. Their conclusions were based on data collected at the Rice University Locomotion Laboratory, under the direction of Professor Peter Weyand. Pistorius hopes to run in the 400-meter race at the Beijing Olympics this summer.

Based on the teams findings, the Court of Arbitration for Sports (CAS) in Lausanne, Switzerland, has ruled that Pistorius is eligible to participate in International Association of Athletics Federations (IAAF) sanctioned competitions. If he qualifies for the 2008 Beijing games, Pistorius would be the first disabled athlete ever to run against able-bodied athletes in an Olympic event.

The teams findings were presented to the CAS April 29-30 by Herr and Professor Rodger Kram of the University of Colorado at Boulder, and provided the foundation for Pistorius appeal to overturn the IAAF decision that previously banned him from running against able-bodied athletes in races that are governed by IAAF rules. The team's findings were presented at the CAS, where Pistorius was represented by the international law firm of Dewey & LeBoeuf on a pro-bono basis.

In addition to Herr, Weyand and Kram, the panel of experts included Professor Matthew Bundle from the University of Wyoming, an expert in the energetics and mechanics of sprinting performance; Craig McGowan, from the University of Texas at Austin, a leading authority on muscle, tendon and joint mechanics; Alena Grabowski, from the Massachusetts Institute of Technology, an expert in human locomotor energetics and biomechanics; and Jean-Benot Morin from the University of Saint-Etienne, an expert in the mechanics of human running performance.

None received compensation for their research or participation in the hearing. The authors plan to submit the study to a peer-reviewed journal now that the legal case has been settled.

The scientific team was asked to evaluate the IAAFs initial claim that the Cheetah Flex-Foot prostheses (J-shaped, high-performance prostheses used for running) worn by Pistorius give him an advantage over able-bodied runners. The team concluded that the scientific evidence put forth by the IAAF investigation to ban Pistorius was fundamentally flawed. While an athletes performance in sprints of very short duration is determined almost entirely by mechanical factors, in races of longer duration, such as the 400m, performance depends on both mechanical and metabolic factors, said Herr, a bilateral amputee who heads the MIT Media Labs Biomechatronics research group.

Based on this performance link, the scientists refuted the IAAF findings on two major points: the speed-duration relationship and rates of metabolic energy expenditure.

Specifically, the scientists concluded that:

  • Pistorius ability to maintain speed over the course of longer sprints--his speed-duration relationship--is essentially identical to that of able-bodied runners, indicating that he fatigues in the same manner as able-bodied sprinters.

  • Pistorius rates of metabolic energy expenditure do not differ from elite non-amputee runners. In particular, he has nearly the same running economy, or rate of oxygen consumption at submaximal speeds, and a similar maximal rate of oxygen consumption as elite non-amputee runners.

"Based on the data collected at Rice, the blades do not confer an enhanced ability to hold speed over a 400m race," Weyand said. "Nor does our research support the IAAF's claims of how the blades provide some sort of mechanical advantage for sprinting."

The study commissioned by the IAAF claimed that Pistorius has a 25 percent energetic advantage at 400m race speeds. That claim is specious because anaerobic energy supply cannot be quantified, Kram said.

In summary, the team of experts unanimously concluded that the IAAF allegations were not scientifically valid.


Contact: David Ruth
Rice University

Related biology news :

1. Shell-breaking crabs lived 20 million years earlier than thought
2. BGSU undergraduates to pilot groundbreaking genome project
3. Scientists discover record-breaking hydrogen storage materials for use in fuel cells
4. Speed plays crucial role in breaking proteins H-bonds
5. Groundbreaking Canada-US study proves link between emissions and mercury pollution in fish
6. Groundbreaking Canada-US study proves link between emissions and mercury pollution in fish
7. UC health news: molecular pathway may predict chemotherapy effectiveness
8. New study casts further doubt on risk of death from higher salt intake
9. Crystal (eye) ball: Study says visual system equipped with future seeing powers
10. Warming climate is changing life on global scale, says new study
11. NASA study links Earth impacts to human-caused climate change
Post Your Comments:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... , November 26, 2015 ... device company specializing in imaging technologies, announced today that it ... as part of the Horizon 2020 European Union Framework Programme ... a large-scale clinical trial in breast cancer. , ... , --> --> The ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
Breaking Biology Technology: